12-Month effect of Tafamidis on the clinical progression of cardiac amyloidosis in a single centre cohort

Back

HFA Premium Access

12-Month effect of Tafamidis on the clinical progression of cardiac amyloidosis in a single centre cohort

Session: ePosters in chronic heart failure - pharmacotherapy 3

Topic: Pharmacotherapy

Speaker: Doctor R. Carvalheiro (Lisbon, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ricardo Carvalheiro

University Hospital Lisboa Central, Lisbon (Portugal)

0 follower

4 more presentations in this session

The role of intermittent levosimendan infusions in patients with advanced heart failure: is it enough?

Speaker: Doctor I. Campos (Penafiel, PT)

Predictors of complete evidence-based treatment implementation at hospital discharge of acute heart failure with reduced LVEF in a real-world population

Speaker: Doctor S. Ruiz Bustillo (Barcelona, ES)

Optimizing heart failure management: impact of quadruple therapy initiation at discharge following decompensation events in patients with reduced ejection fraction

Speaker: Doctor C. Gregorio (Lisbon, PT)

Tolerance and clinical response to SGL2 inhibitors in Fabry disease

Speaker: Doctor I. Mattig (Berlin, DE)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 3

Speakers: Doctor R. Carvalheiro, Doctor I. Campos, Doctor S. Ruiz Bustillo, Doctor C. Gregorio, Doctor I. Mattig

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources